"Cell Line, Tumor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cell line derived from cultured tumor cells.
| Descriptor ID |
D045744
|
| MeSH Number(s) |
A11.251.210.190 A11.251.860.180
|
| Concept/Terms |
Cell Line, Tumor- Cell Line, Tumor
- Cell Lines, Tumor
- Line, Tumor Cell
- Lines, Tumor Cell
- Tumor Cell Lines
- Tumor Cell Line
|
Below are MeSH descriptors whose meaning is more general than "Cell Line, Tumor".
Below are MeSH descriptors whose meaning is more specific than "Cell Line, Tumor".
This graph shows the total number of publications written about "Cell Line, Tumor" by people in this website by year, and whether "Cell Line, Tumor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 9 | 9 |
| 2004 | 0 | 20 | 20 |
| 2005 | 1 | 22 | 23 |
| 2006 | 0 | 29 | 29 |
| 2007 | 0 | 28 | 28 |
| 2008 | 0 | 39 | 39 |
| 2009 | 0 | 53 | 53 |
| 2010 | 0 | 40 | 40 |
| 2011 | 0 | 52 | 52 |
| 2012 | 0 | 27 | 27 |
| 2013 | 0 | 54 | 54 |
| 2014 | 1 | 38 | 39 |
| 2015 | 0 | 57 | 57 |
| 2016 | 0 | 60 | 60 |
| 2017 | 1 | 49 | 50 |
| 2018 | 0 | 50 | 50 |
| 2019 | 0 | 55 | 55 |
| 2020 | 0 | 45 | 45 |
| 2021 | 0 | 39 | 39 |
| 2022 | 0 | 21 | 21 |
| 2023 | 0 | 9 | 9 |
| 2024 | 0 | 26 | 26 |
| 2025 | 0 | 11 | 11 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Line, Tumor" by people in Profiles.
-
Using MUC2 mucin producing tumorigenic human goblet-like cells to uncover functional properties of the mucus barrier. Gut Microbes. 2025 Dec; 17(1):2542385.
-
Exosome-Associated MTA1 in Circulation Is Elevated During Breast Cancer Progression. FASEB J. 2025 Jul 31; 39(14):e70872.
-
Novel fusion superkine, IL-24S/IL-15, enhances immunotherapy of brain cancer. J Immunother Cancer. 2025 Jun 22; 13(6).
-
CD51 promotes gastric cancer stemness via blocking Numb-mediated Notch1 degradation. Cancer Lett. 2025 Oct 01; 629:217886.
-
CHD4 drives gastric cancer metastasis via MYH9/GSK3?/?-catenin axis and WNT/EMT pathway activation. Cancer Lett. 2025 Sep 28; 628:217813.
-
P53-Induced Autophagy Degradation of NKX3-2 Improves Ovarian Cancer Prognosis. Cells. 2025 05 22; 14(11).
-
A zinc transporter drives glioblastoma progression via extracellular vesicles-reprogrammed microglial plasticity. Proc Natl Acad Sci U S A. 2025 May 06; 122(18):e2427073122.
-
Combinatorial screen with apoptosis pathway targeted agents alrizomadlin, pelcitoclax, and dasminapant in multi-cell type tumor spheroids. SLAS Discov. 2025 Jun; 33:100230.
-
Synergistic Therapeutic Effects of Prussian Blue Erbium-Doped Hydroxyapatite Nanoparticles in Photothermal Photodynamic Cancer Therapy. ACS Biomater Sci Eng. 2025 May 12; 11(5):2639-2652.
-
Lipid metabolic reprogramming drives triglyceride storage and variable sensitivity to FASN inhibition in endocrine-resistant breast cancer cells. Breast Cancer Res. 2025 Mar 07; 27(1):32.